Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TOMM40 pseudogene 3 (TOMM40P3) is one of five highly homologous pseudogenes related to the TOMM40 gene in the human genome. While the TOMM40P3 locus produces RNA transcripts in human cell lines and tissues, there is currently no evidence of protein-coding function or direct biological activity. It may regulate TOMM40 transcription levels and provide regulatory RNA species that buffer against transcriptional fluctuations, but its precise biological roles are undefined. TOMM40P3 is not considered a therapeutic target, and no drugs or disease associations are documented. Importantly, TOMM40P3 and other pseudogene RNAs complicate the molecular measurement of TOMM40 itself, as conventional assays often struggle to distinguish true TOMM40 mRNA from pseudogene-derived transcripts. TOMM40 (the canonical protein) is implicated in mitochondrial function and Alzheimer's disease risk, but these findings do not directly extend to TOMM40P3[1][4][5][6].\n\nIf you are seeking a druggable target, focus on Mitochondrial import receptor subunit TOM40 homolog (TOMM40), not TOMM40P3[3][6].
None known. There is no evidence of drug mechanism of action involving TOMM40P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOMM40 pseudogene 3 (TOMM40P3).